Aaron Sandusky and Cannabis’s Legal Gray Zone

“How is it that in state court what we were fighting over was zoning—a hundred-dollar civil infraction—but in federal court I was fighting for my life?” Sandusky asked.

Working in legal cannabis and hemp, we encounter stories of operators who worked openly within state-authorized systems yet still ended up incarcerated under federal law. Few capture that contradiction as starkly as Aaron Sandusky, the founder of G3 Holistics.

His story begins in the first generation of California’s medical cannabis industry, when a business could be protected from state criminal penalties, prohibited by a city’s zoning code and prosecuted as drug trafficking by the federal government—all at the same time.

That unstable legal conflict followed Sandusky through raids, a federal trial, a ten-year mandatory-minimum sentence and years of appeals.

A public business in an unsettled system

G3 Holistics was not hidden. A contemporaneous legal summary of the case describes how Upland refused the company’s business-license application because dispensaries were prohibited citywide. After G3 declined to close, Upland sought an injunction to have the operation declared a public nuisance.

G3 argued that California’s medical-cannabis laws prevented a citywide ban, but a state appellate court upheld an injunction against it in 2011. In 2013, the California Supreme Court settled the broader question in City of Riverside v. Inland Empire Patients Health and Wellness Center, holding that cities could ban dispensaries through their land-use powers.

Sandusky remembers the period as an effort to make the government answer him. “I was on Route 66,” he said. “I wasn’t operating a clandestine operation. I was in the paper numerous times because we had a case moving through the courts.”

He said he spoke at city council meetings, hired attorneys and supported local candidates sympathetic to medical cannabis. In his telling, G3 drew attention precisely because it was public and political.

“I was there and present. I wasn’t hiding,” he said. “I was talking to them, giving them information, telling them, ‘We don’t have to do this. I want to work with you. I don’t want to work against you.’”

From a zoning fight to federal prison

According to the U.S. Attorney’s Office, federal authorities warned Sandusky in writing in October 2011 that G3’s stores violated federal law. He closed locations in Colton and Moreno Valley but kept the Upland operation open after two searches and federal asset-forfeiture actions.

Sandusky describes that decision as an attempt to keep the underlying legal challenge alive. “We opened and operated to try to preserve and protect the case that we were fighting,” he said. “It was important for us to get a decision.”

A federal grand jury indicted Sandusky and five others connected to G3 in June 2012. The other five pleaded guilty; Sandusky went to trial. “I didn’t take a deal,” he told us. “I went to trial because we weren’t doing anything wrong.”

Federal prosecutors saw G3 differently, characterizing Sandusky in a sentencing memorandum as an “unrepentant manipulator” who built a veneer of legitimacy around a commercial drug operation. The government said G3 distributed hundreds of pounds of marijuana and linked the case to at least 1,000 plants. Under the federal Controlled Substances Act, state-law compliance was not a defense—and Upland disputed that G3 complied locally.

Sandusky says jurors heard that trafficking case without the state-law context through which he understood his actions.

“They gave me a gag order inside the courtroom,” he said. “I couldn’t tell the jury that I was operating under the protection of the California courts. Outside the courtroom, they gagged me so I couldn’t talk to the media and tell everybody what was going on inside.”

The jury convicted him of conspiracy and possession with intent to distribute marijuana, finding that each count involved at least 1,000 plants. It deadlocked on four other counts, later dismissed. On January 7, 2013, Judge Percy Anderson imposed the mandatory minimum: concurrent 120-month sentences.

“I got the mandatory minimum for a nonviolent, first-time offender,” Sandusky said. “Ten years instead of life.”

A protection that arrived too late

Congress changed the legal landscape after Sandusky was already in prison. The Rohrabacher–Farr appropriations rider, first enacted in 2014, limited Justice Department interference with state medical-marijuana programs. In 2016, the Ninth Circuit held in United States v. McIntosh that it could bar spending on prosecutions of people in strict compliance with state law.

Sandusky invoked the rider against his continued imprisonment. In 2019, the Tenth Circuit ruled that he could pursue the claim, without vacating his conviction or deciding that G3 had complied with California law. By then, years had passed.

“Cases like mine were used as why we needed to pass that law,” Sandusky said. “Then trying to use that same law to get out of prison took me the whole time.” He described litigating from prison with an old typewriter, correction tape, and long waits for limited telephone access.

“What’s important to me, they can’t take”

Sandusky completed probation in 2025 and is now looking for a way back into cannabis. He calls what happened wrong, but refuses to organize the rest of his life around bitterness.

“I went through it. I took it on the chin. I did my time, and it was wrong, but I can’t change that,” he said. “They took everything they could from me that I physically touched in my life, pretty much. When you go away for that long, you’re not left with much. But that’s just stuff. What’s important to me, they can’t take.”

Sandusky traces some of his commitment to medical-cannabis access to watching his father die from a brain tumor. That experience made him sympathetic to seriously ill patients seeking relief. “They should have access to whatever it is that they want,” he said.

He remembers customers undergoing chemotherapy who told him they worried that a positive cannabis test could affect their insurance or treatment. Some, he said, came to G3 simply because it was somewhere other than home to wait and worry.

Those relationships followed him into court.

“I had a member of [G3 Holistics] put his house up to bail me out,” Sandusky said. “I had people who were fighting for their lives come into my courtroom. These people were fighting for what life they had left, and they were showing up there with me.”

What does the industry owe?

Sandusky is reentering a cannabis marketplace that grew while he was incarcerated. Asked whether the industry owed him for absorbing early legal risks, he joked, “Damn it, I’m owed. You owe me. I’m entitled.” Then he rejected the premise.

“Nobody gets anything for free,” he said. “You’ve got to bring something to the table or you’re not going to last anywhere. Pick your space, and know it.”

He wants to participate—to work on policy, build products and show what he can contribute. “I believe wholeheartedly in the plant,” he said. “I’ve made a lot of sacrifices for it. I took it on the chin, and I’m coming back. I guess it’s going to take a little more than that to keep me away.”

A new chapter

A chance meeting during a Washington, D.C., layover this summer connected Sandusky with JointLab, a growing pre-roll manufacturer looking to expand in Southern California. A few weeks later, he flew to Santa Cruz to meet the team and tour its facilities.

“The scale of what I saw on the cultivation and processing sides absolutely blew my mind,” he said. “Seeing over 100 acres of flowering cannabis plants—all permitted and tagged by the state—it took a while to process.”

“Aaron took a bullet for all of us. It’s that simple,” said JointLab’s head of operations, Mike Lyons. “But that ain’t why we brought him in. He’s a smart, accomplished entrepreneur who quickly clicked with our team.” Sandusky has now joined JointLab as the head of Southern California Sales & Business Development.

Joints for justice

During his incarceration, Sandusky received help from Freedom Grow, a nonprofit supporting cannabis prisoners and their families; he now serves on its board. His first JointLab initiative, Freedom Rolls, will direct a portion of each sale to the group’s commissary assistance and holiday gifts for prisoners’ families.

The danger of getting Schedule III wrong

Sandusky’s experience shapes how he views federal reform. In April 2026, the Justice Department placed FDA-approved marijuana products and products covered by qualifying state medical-marijuana licenses into Schedule III. Broader rescheduling remains unfinished, and Sandusky worries about the seams between medical and recreational markets, state licenses and federal product rules.

“Everybody’s guessing at this point,” he said. “The FDA has rules for how drugs are distributed. They’re not going to just not enforce them. What are the institutions that comply with the FDA process going to say about the ones that don’t? Are those going to be the lawsuits? There’s a lot of wiggle there.”

“Let’s not get it wrong so it can be used again as a weapon, like it was in my case,” he said. “We don’t need to risk people’s lives like that.”

Near the end of our conversation, Sandusky reduced the conflict to its human scale.

“There’s a human toll that we suffer while these guys are battling over control of a substance that shouldn’t be under anybody’s control,” he said. “We should be able to study it, identify it and create from it. But it grows readily available everywhere. Leave it at that.”

The cannabis industry cannot give Sandusky those years back. His request is more immediate: a place at the table and a fair chance to show what he can do.

“That’s all we can ask for—an opportunity to compete,” he said.